Leaflet LUIVAC 3mg tablets


Indicated for: prevention of recurrent respiratory infections

Route of administration: oral

Substance: biological products (bacterial lysates) (immunomodulator)

ATC: L03AXN1 (Antineoplastic and immunomodulating agents | Immunostimulants | Other immunostimulants)

Biological products based on bacterial lysates are used to stimulate the immune system in the prevention and treatment of recurrent respiratory infections. They contain fragments of inactivated bacteria that stimulate the body's immune response.

The product is administered orally, usually in the form of capsules or tablets, as directed by the doctor. It is important to follow the treatment regimen to achieve maximum benefits.

Side effects may include nausea, abdominal discomfort, or, in rare cases, allergic reactions.

Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of biological products based on bacterial lysates.

General data about LUIVAC 3mg

  • Substance: biological products (bacterial lysates)
  • Date of last drug list: 01-10-2024
  • Commercial code: W64346001
  • Concentration: 3mg
  • Pharmaceutical form: tablets
  • Quantity: 28
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: DAIICHI SANKYO EUROPE GMBH - GERMANIA
  • Holder: ALVOGEN MALTA OPERATIONS (ROW) LTD. - MALTA
  • Number: 4595/2012/01
  • Shelf life: 2 years